The cancer biomarker problem
Top Cited Papers
- 2 April 2008
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 452 (7187), 548-552
- https://doi.org/10.1038/nature06913
Abstract
Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.Keywords
This publication has 26 references indexed in Scilit:
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potencyJournal of Clinical Investigation, 2007
- Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activityProceedings of the National Academy of Sciences, 2007
- Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancerProceedings of the National Academy of Sciences, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- High-throughput oncogene mutation profiling in human cancerNature Genetics, 2007
- Genomic signatures to guide the use of chemotherapeuticsNature Medicine, 2006
- Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencingNature Medicine, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004